Try our Advanced Search for more refined results

Perrigo Company v. United States of America

  1. January 28, 2020

    Drugmaker Asks For Info Protection In $163M Perrigo-US Row

    An Israeli drugmaker alleged by the U.S. to have made a distribution agreement with Perrigo that lacked economic substance has asked a Michigan federal court to safeguard its trade secrets while Perrigo pursues a $163.4 million tax refund in court.

  2. October 11, 2019

    Court Allows $163M Perrigo-US Tax Dispute To Continue

    A Michigan federal court on Friday denied both the U.S. and Perrigo summary judgment in their $163 million international tax dispute over a Perrigo offshore subsidiary's heartburn drug contract.

  3. June 06, 2019

    Perrigo Set Up Israeli Co. To Skip Tax, US Says In $163M Row

    Perrigo created an Israeli subsidiary in 2006 as an "empty box," and the assignment of a heartburn drug contract to the subsidiary should be disregarded in a $163 million tax dispute, the U.S. has told a Michigan federal court.

  4. May 16, 2019

    Perrigo Says IRS Can't Undo Tax Structure Approval In $163M Row

    Generic drug manufacturer Perrigo told a Michigan federal court that the Internal Revenue Service shouldn't be able to reverse previous approval of the company's international tax structure in its $163.4 million international tax dispute.

  5. April 16, 2019

    No Settlement In Sight In Perrigo's $163M Tax Row With U.S.

    The U.S. government and Irish-registered generic pharmaceutical maker Perrigo Co. have failed to resolve a $163.4 million tax dispute during a settlement conference, according to minutes of the proceeding in a Michigan federal court.

  6. January 22, 2019

    Judge Nixes Perrigo's Bid For IRS Report In $163M Tax Row

    A Michigan federal judge has denied pharmaceutical company Perrigo Co.'s efforts to force the U.S. to produce an Internal Revenue Service economist's report in a $163.4 million tax dispute.

  7. December 17, 2018

    Perrigo Wants IRS Economist's Audit Report In $163.5M Row

    Generic pharmaceutical giant Perrigo Co. has demanded in a Michigan federal court that the U.S. government turn over an economist's report produced during an Internal Revenue Service audit that led to a $163.5 million tax-refund dispute.

  8. December 06, 2018

    Feds Blocked Again From Deposing Israelis In $163M Tax Row

    The government cannot depose two Israeli executives about their company's business with U.S. drugmaker Perrigo in a $163.5 million tax dispute, with a Michigan federal court again ruling Thursday it would be too expensive.

  9. November 14, 2018

    Israeli Docs Unnecessary In $163.5M Tax Suit, Perrigo Says

    The U.S. government's narrowed requests for Israeli court documents and depositions of two Israeli executives in a $163.5 million tax refund dispute are unnecessary and will yield duplicative evidence, Perrigo Co. has told a Michigan federal court.

  10. October 31, 2018

    US Narrows Bid For Israeli Court Docs In $163.5M Tax Row

    The Internal Revenue Service has narrowed its bid to obtain documents from Israeli courts in a $163.5 million tax dispute with a generic pharmaceutical company after a federal judge rejected an earlier attempt this year as being too broad.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!